These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9002395)

  • 21. Psychostimulants for depression.
    Levin R
    Am Fam Physician; 1991 Sep; 44(3):758, 763. PubMed ID: 1678915
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data.
    Morrato EH; Staffa JA
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):104-12. PubMed ID: 16821248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of psychostimulants in general psychiatry. A reconsideration.
    Chiarello RJ; Cole JO
    Arch Gen Psychiatry; 1987 Mar; 44(3):286-95. PubMed ID: 2881528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What are the pharmacologic considerations when treating depression in patients with HIV infection?
    Swenson JR
    J Psychiatry Neurosci; 1998 May; 23(3):200. PubMed ID: 11499431
    [No Abstract]   [Full Text] [Related]  

  • 25. Augmentation strategies for treatment-resistant depression.
    Carvalho AF; Machado JR; Cavalcante JL
    Curr Opin Psychiatry; 2009 Jan; 22(1):7-12. PubMed ID: 19122528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of stimulants in the medically ill.
    Masand PS; Tesar GE
    Psychiatr Clin North Am; 1996 Sep; 19(3):515-47. PubMed ID: 8856815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A suggestion: give stimulants and euphorizing agents to severely depressed people].
    Lings S
    Ugeskr Laeger; 2010 Apr; 172(17):1319; discussion 1319. PubMed ID: 20449921
    [No Abstract]   [Full Text] [Related]  

  • 28. Sleep practitioners need to be aware of new changes in the labeling of pemoline (CYLERT).
    Littner M
    Sleep; 1999 Nov; 22(7):833. PubMed ID: 10566901
    [No Abstract]   [Full Text] [Related]  

  • 29. Methylphenidate and psychotic depression.
    Ng BK
    Clin Neuropharmacol; 2009; 32(3):177. PubMed ID: 19483495
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of dantromin in geriatrics].
    Adamska-Dyniewska H
    Pol Tyg Lek; 1967 Apr; 22(17):641-3. PubMed ID: 4384172
    [No Abstract]   [Full Text] [Related]  

  • 31. [New orientation in the pharmacological management of mental retardation].
    De Cándenas V
    Rev Clin Esp; 1969 Jan; 112(2):183-92. PubMed ID: 4388803
    [No Abstract]   [Full Text] [Related]  

  • 32. Stimulant treatment of adult attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Psychiatr Clin North Am; 2004 Jun; 27(2):361-72. PubMed ID: 15064002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmentation strategies for treatment-resistant depression: a literature review.
    Carvalho AF; Cavalcante JL; Castelo MS; Lima MC
    J Clin Pharm Ther; 2007 Oct; 32(5):415-28. PubMed ID: 17875106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Deadyn: treatment of behavior disorders].
    Dall'Oglio GN
    Riv Sper Freniatr Med Leg Alien Ment; 1967 Apr; 91(2):576-82. PubMed ID: 4384083
    [No Abstract]   [Full Text] [Related]  

  • 35. Prolonged P300 latency in attention deficit hyperactivity disorder predicts poor response to imipramine.
    Sangal JM; Sangal RB; Persky B
    Clin Electroencephalogr; 1996 Oct; 27(4):191-201. PubMed ID: 9465283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested.
    Rep Med Guidel Outcomes Res; 2000 Feb; 11(4):1-2, 5-7. PubMed ID: 11768409
    [No Abstract]   [Full Text] [Related]  

  • 37. Influences of cylert upon memory changes with ECT.
    Small IF; Sharpley P; Small JG
    Am J Psychiatry; 1968 Dec; 125(6):837-40. PubMed ID: 4386991
    [No Abstract]   [Full Text] [Related]  

  • 38. A rapid response with psychostimulants in the treatment of depressed persons with medical illnesses.
    Roy M; Bernier J
    Can J Psychiatry; 1999 Apr; 44(3):283-4. PubMed ID: 10225132
    [No Abstract]   [Full Text] [Related]  

  • 39. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.
    Rothman RB; Baumann MH; Dersch CM; Romero DV; Rice KC; Carroll FI; Partilla JS
    Synapse; 2001 Jan; 39(1):32-41. PubMed ID: 11071707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selfaggressiveness: a new type of behavioral change induced by pemoline.
    Genovese E; Napoli PA; Bolego-Zonta N
    Life Sci; 1969 May; 8(9):513-5. PubMed ID: 4389346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.